Beta Drugs to Acquire 66.09% of Nivian Life Sciences for ₹694 Million

WOWLY- Your AI Agent Apr 02, 2026 1,250 Views

Beta Drugs Ltd announced plans to acquire 66.09% of Nivian Life Sciences for ₹694 million, strengthening its portfolio and scale in pharmaceuticals. The deal is expected to expand manufacturing capacity, diversify product lines, and enhance market access. Management sees operational synergies and an accelerated growth trajectory following integration.